
Tuesday, May 20, 2025 9:38:15 AM
Recent NRSN News
- NeuroSense Therapeutics Announces Successful Completion of Commercial Manufacturing Scale-Up for PrimeC in Preparation for Potential Canadian Market Launch • PR Newswire (US) • 05/07/2025 12:45:00 PM
- NeuroSense Therapeutics Releases Letter to Shareholders Outlining Clinical Progress, Regulatory Strategy, and Partnership Update • PR Newswire (US) • 04/24/2025 01:09:00 PM
- NeuroSense Therapeutics Announces Transformative Phase 2b MicroRNA Data, Highlighting PrimeC's Promise as a Disease-Modifying ALS Treatment • PR Newswire (US) • 04/09/2025 12:30:00 PM
- NeuroSense Therapeutics Reports Year End 2024 Financial Results and Provides Business Updates • PR Newswire (US) • 04/07/2025 09:14:00 PM
- NeuroSense Therapeutics to Present New Data from PrimeC's Phase 2b Trial in ALS at the Annual American Academy of Neurology Meeting • PR Newswire (US) • 04/04/2025 01:10:00 PM
- Market Alert: NeuroSense Therapeutics Advances Toward Early Canadian Commercialization of ALS Drug • Business Wire • 03/20/2025 02:30:00 PM
- PESG Releases Report on NeuroSense Therapeutics: Groundbreaking ALS Therapy Signals Massive Potential Opportunity in Billion Dollar Treatment Landscape • Business Wire • 03/17/2025 12:30:00 PM
- NeuroSense Regains Compliance with Nasdaq's Minimum Equity Requirement • PR Newswire (US) • 01/06/2025 02:00:00 PM
- NeuroSense Therapeutics Enters Binding Term Sheet to Advance PrimeC for ALS • PR Newswire (US) • 12/23/2024 02:00:00 PM
- NeuroSense Provides Business Update and Third Quarter 2024 Financial Results • PR Newswire (US) • 12/18/2024 03:25:00 PM
- NeuroSense Receives Positive FDA Feedback on Phase 3 Study Design for PrimeC • PR Newswire (US) • 12/11/2024 02:25:00 PM
- NeuroSense Announces Completion of PARADIGM Study Highlighting PrimeC's Significant Efficacy and Survival Benefits in ALS • PR Newswire (US) • 12/04/2024 01:30:00 PM
- NeuroSense Therapeutics Announces $5 Million Private Placement at Premium to Market Price • PR Newswire (US) • 12/02/2024 01:30:00 PM
- NeuroSense Therapeutics to Participate in the 2024 International Symposium on ALS/MND • PR Newswire (US) • 11/21/2024 02:20:00 PM
- NeuroSense Secures Key FDA Meeting to Advance its Phase 3 ALS Trial and NDA Submission • PR Newswire (US) • 10/28/2024 12:30:00 PM
- New Analysis Shows PrimeC Significantly Improves Key miRNAs in ALS Patients • PR Newswire (US) • 10/24/2024 12:30:00 PM
- NeuroSense Advances Plans for Early Commercialization of Groundbreaking ALS Treatment in Canada, Provides Further Updates • PR Newswire (US) • 10/15/2024 01:15:00 PM
- NeuroSense Therapeutics Plans to File for Early Commercialization of ALS Treatment in Canada • PR Newswire (US) • 10/09/2024 01:00:00 PM
- NeuroSense Therapeutics Announces Acceptance of Two PrimeC Abstracts at the 2024 NEALS Annual Meeting • PR Newswire (US) • 10/07/2024 01:00:00 PM
- NeuroSense Therapeutics Granted Key U.S. Patent for Novel PrimeC Formulation, its Lead Asset for ALS and Alzheimer's • PR Newswire (US) • 09/24/2024 01:05:00 PM
- NeuroSense Regains Compliance with NASDAQ Minimum Bid Price Rule • PR Newswire (US) • 09/24/2024 01:00:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 08/30/2024 09:00:06 PM
- NeuroSense Therapeutics Announces Receipt of Nasdaq Minimum Bid Price Notification • PR Newswire (US) • 08/30/2024 08:30:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 08/28/2024 11:05:11 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 08/26/2024 12:00:08 PM
Authentic Holdings Inc. Partnership with Swerve TV Debuts with Highly Successful 'Ring of Combat' Live Broadcast • AHRO • Jun 18, 2025 12:45 PM
ePIC Blockchain Signs LOI with A.R.T. Digital to Redefine Bitcoin Miner Design with Breakthrough Air-Cooling Technology • CGAC • Jun 18, 2025 12:41 PM
Avant Technologies' JV Partner, Ainnova, Begins Diabetic Retinopathy Screenings with Leading Pharmacies • AVAI • Jun 17, 2025 8:00 AM
Cannabix Technologies Receives Notice of Allowance from USPTO for Contactless Breath Analysis • BLO • Jun 17, 2025 8:00 AM
A.R.T. Digital Holdings (OTC: CGAC) Secures Non-Dilutive Financing for George West Site Supporting NASDAQ: BTBT • CGAC • Jun 17, 2025 5:07 AM
VAYK to Acquire Up to $9 million in Time-share Vacation Properties Through Non-Cash Deals • VAYK • Jun 11, 2025 9:45 AM